## **Core Concept**
Vitamin D dependent rickets, also known as vitamin D-resistant rickets, is a rare genetic disorder caused by mutations in the genes encoding for the vitamin D receptor. This condition leads to impaired mineralization of bone tissue. The primary goal of treatment is to bypass the receptor defect and promote calcium absorption.

## **Why the Correct Answer is Right**
The correct answer, **Calcitriol (1,25-dihydroxyvitamin D3)**, is the hormonally active metabolite of vitamin D. It directly stimulates intestinal calcium absorption and bone mineralization. In cases of vitamin D-dependent rickets, the defect lies in the receptor for 1,25-dihydroxyvitamin D3. Therefore, administering calcitriol bypasses the need for the body to convert vitamin D into its active form, effectively treating the condition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Vitamin D2 (ergocalciferol) requires conversion to its active form (1,25-dihydroxyvitamin D3) in the body, which may not be effectively achieved in vitamin D-dependent rickets due to the receptor defect.
- **Option B:** Vitamin D3 (cholecalciferol) also needs to be converted into calcitriol to be effective. This conversion may be impaired or inefficient in patients with vitamin D-dependent rickets.
- **Option D:** Dihydrotachysterol is a synthetic form of vitamin D that has a rapid onset of action but does not directly address the receptor defect seen in vitamin D-dependent rickets.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with vitamin D-dependent rickets type 2 (a form of vitamin D-resistant rickets) often require high doses of calcitriol and calcium supplements to manage their condition effectively. Monitoring of serum calcium, phosphate levels, and alkaline phosphatase activity is crucial to adjust the treatment regimen.

## **Correct Answer:** . **Calcitriol**